Oral Pharmacotherapy for Benign Essential Blepharospasm

Int Ophthalmol Clin. 2018 Winter;58(1):33-47. doi: 10.1097/IIO.0000000000000208.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Administration, Oral
  • Blepharospasm / drug therapy*
  • Cholinergic Antagonists / administration & dosage*
  • Dopamine Agents / administration & dosage*
  • GABA Antagonists / administration & dosage*
  • Histamine Antagonists / administration & dosage*
  • Humans
  • Treatment Outcome

Substances

  • Cholinergic Antagonists
  • Dopamine Agents
  • GABA Antagonists
  • Histamine Antagonists

Supplementary concepts

  • Benign essential blepharospasm